Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
50 participants
INTERVENTIONAL
2025-12-05
2027-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The method is used to identify individual bioelectrical reactivity associated with the presence and persistence of pathological factors and to assess patient-specific responses to tested medicinal substances.
The study involves a single-session, non-invasive diagnostic procedure without administration of pharmacological treatment. The primary objective is the methodological evaluation of the diagnostic approach and the characterization of the detected bioelectrical response patterns in the studied population.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings
NCT04352764
Evaluation of Rapid Diagnostic Solutions, Serological and Molecular Tests for COVID-19
NCT04405492
Development and Verification of a New Coronavirus Multiplex Nucleic Acid Detection System
NCT04311398
COVID-19 Diagnostic Self-testing Using Virtual Point-of-care
NCT04348864
Investigational Performance Evaluation of the Nanomix eLab® COVID-19 Rapid Antigen Panel With Samples From COVID-19 Positive and Negative Human Subjects
NCT04667442
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The method is used to identify individual bioelectrical reactivity associated with the presence and persistence of pathological factors and to assess patient-specific responses to tested medicinal substances.
The study involves a single-session, non-invasive diagnostic procedure without pharmacological treatment. The primary objective is the methodological evaluation of the diagnostic approach and the characterization of the detected bioelectrical response patterns in the studied population.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diagnostic Assesment Arm
This single-arm study includes participants undergoing a non-invasive electrodiagnostic assessment to evaluate bioelectrical response patterns associated with viral antigen persistence. No therapeutic intervention is administered.
Electrodiagnostic Bioelectrical Assessment
A non-invasive diagnostic procedure performed during a single session to assess bioelectrical response patterns associated with viral antigen persistence. Measurements are obtained using standardized bioelectrical assessment techniques without administration of any therapeutic agents or interventions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Electrodiagnostic Bioelectrical Assessment
A non-invasive diagnostic procedure performed during a single session to assess bioelectrical response patterns associated with viral antigen persistence. Measurements are obtained using standardized bioelectrical assessment techniques without administration of any therapeutic agents or interventions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* History of confirmed SARS-CoV-2 infection
* Persistent symptoms consistent with Long COVID lasting ≥12 weeks after acute infection
* Ability to provide informed consent
* Willingness to undergo non-invasive bioelectrical diagnostic assessment
Exclusion Criteria
* Severe uncontrolled medical or psychiatric conditions that may interfere with diagnostic assessment
* Implanted electronic medical devices (e.g., pacemaker)
* Pregnancy or breastfeeding
* Inability to comply with study procedures
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oncology Center,Ministry Of Heath,Uzbekistan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Naylya Djumaeva, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
Reseacrh Institute of Virology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Institute of Virology
Tashkent, , Uzbekistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9/36-2216
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.